Company news
Cynata Therapeutics Limited (ASX:CYP) news
Cynata Therapeutics Limited news releases on 6ix. Latest, Oct 31, 2016: Activities Report & Appendix 4C
Press releases — page 5
Activities Report & Appendix 4C
October 31, 2016
Efficacy for CYP MSC Technology in Preclinical Asthma Study
October 16, 2016
UK Regulatory Authority Approves Cynata GvHD Clinical Trial
September 19, 2016
CYP Determines not to proceed with Regience Investment Offer
September 5, 2016
CYP & FUJIFILM Sign Non-Binding Terms Sheet
September 4, 2016
Cynata Files Application to Commence Phase 1 Clinical Trial
July 31, 2016
Cynata Receives Investment Offer from Regience
June 30, 2016
Cynata Prepares for Phase 1 Clinical Trial
June 20, 2016
Cynata Enters Agreement with apceth GmbH & Co KG
May 8, 2016
CYP Manufactures CT Product-Files Further Patent Application
May 5, 2016
Decision to Grant Patent for Cymerus MSC Technology in Japan
May 2, 2016
Cynata & Regience Extend Entitlement Period
April 29, 2016
Compelling Results from Pre-Clinical Stem Cell Study in GvHD
April 6, 2016
Cynata Announces Landmark Licensing Deal
March 30, 2016
Cynata Enters Agreement for Strategic Alliance in Japan
March 3, 2016
Cynata Receives $930k R&D Tax Incentive Refund
February 15, 2016
Quarterly Activities Report & Appendix 4C
February 11, 2016
CYP Receives Favourable Advice from UK Regulatory Authority
February 10, 2016